Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Long & Strong with Biotech Buyout Candidate TBP

<< Previous

Bullboard Posts

Next >>

Comment by Ibeechamberinon Dec 29, 2021 1:13pm

131 Views

Post# 34268123

RE:RE:Long & Strong with Biotech Buyout Candidate TBP

Shut yo a$$ up. You always talking $hit. company out of Israel is privately owned so tetra is the ONLY inhaled med cannabis. You and your hating a$$ needs to go smoke a joint and stfu. Fu€king troll. You're just a salty, hateful bag holdin a$$ bit€h. Probably have an avg of .60/$1 some of us are in at .11
maybe you won't make money on this but I will

<< Previous

Bullboard Posts

Next >>

Bombardier delivers Global 6500 aircraft to U.S. Army